InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Markush pharma patent claims supported by Beijing Higher People’s Court

Karry Lai, Hong Kong

A recent decision in China provides some assurance for pharmaceutical patent owners but the direction of Markush claims is still unclear

The Beijing Higher People’s Court in January addressed the issue of whether partial priority should apply to Markush claims. Markush claim is a claim with multiple functionally equivalent chemical entities allowed in one or more parts of the compound.

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates